5.59% -0.0074

Petros Pharmaceuticals Inc (PTPI)

概要ニュース株価時系列 Financials ディスカッション予測株式分割

Relative Volume:

ネットキャッシュフロー:

Petros Pharmaceuticals Inc Stock (PTPI) Company Profile

Petros Pharmaceuticals Inc

Healthcare (1169)

973-242-0005

1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK

PTPI's Discussions on Twitter

PTPI を他の銘柄と比較する

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
PTPI Petros Pharmaceuticals Inc	0.125	1.41M	4.02M	-4.73M	-5.85M	-4.21
ZTS Zoetis Inc	160.46	71.85B	9.26B	2.49B	2.30B	5.47
HLN Haleon Plc Adr	10.08	45.58B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	14.06	44.58B	30.25B	1.37B	5.08B	0.4257
TEVA Teva Pharmaceutical Industries Ltd Adr	16.74	19.18B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	128.60	13.67B	612.78M	-86.37M	-62.91M	-0.87

Petros Pharmaceuticals Inc (PTPI) 最新ニュース

Petros Pharmaceuticals Inc (PTPI) 財務データ

Petros Pharmaceuticals Inc (PTPI)

Petros Pharmaceuticals Inc Stock (PTPI) Company Profile

PTPI を他の銘柄と比較する

Petros Pharmaceuticals Inc (PTPI) 最新ニュース

Form 424B4 Petros Pharmaceuticals, - StreetInsider.com

PTPI stock plunges to 52-week low of $0.15 amid market challenges - Investing.com India

Crude Oil Gains 1.5%; Fluor Shares Plunge Following Downbeat Earnings - Benzinga

Watsco, Septerna, Nike - TradingView

Petros Pharmaceuticals announces pricing of $9.6 million public offering - MSN

Petros Pharmaceuticals Prices $9.6 Million Public Offering of Shares, Warrants -February 18, 2025 at 09:52 am EST - Marketscreener.com

US Stocks Mixed; NY State Business Activity Rises In February - Benzinga

Petros Pharmaceuticals sets public offering at $0.24 per share - Investing.com

Petros Pharmaceuticals prices 40M shares at 24c in public offering - TipRanks

Petros Pharmaceuticals Announces Pricing of $9.6 Million Public Offering of Common Stock and Warrants - ACCESS Newswire

Major Capital Raise: Petros Pharmaceuticals Locks $9.6M Financing DealStrategic Move or Dilution Risk? - StockTitan

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Petros Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference - ACCESS Newswire

Best Penny Stocks for Today (Charts Updated Daily) - Benzinga

Petros Pharmaceuticals Enters into AI Licensing Agreement with Leading Multi-Billion-Dollar Software Provider - ACCESS Newswire

Petros Pharmaceuticals (NASDAQ:PTPI) Trading 5.2% Higher – Still a Buy? - Defense World

Erectile Dysfunction Treatment Drugs Market to Hit USD 5.97 Billion by 2032, Growing at a 6.84% CAGR - EIN News

Analytical Lens: Exploring Perella Weinberg Partners (PWP)’s Financial Story Through Ratios - The Dwinnex

Balance Sheet Breakdown: Petros Pharmaceuticals Inc (PTPI)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Petros Pharmaceuticals Inc’s (PTPI) Stock: A Week-by-Week Analysis - The News Heater

Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil) - ACCESS Newswire

Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final Rules - ACCESS Newswire

Petros Pharmaceuticals Successfully Completes Important Study in Effort to Make STENDRA(R) (avanafil) the First Erectile Dysfunction Medication to Achieve OTC Status - ACCESS Newswire

Johnson & Johnson posts Q4 beat as drug sales offset MedTech weakness - MSN

Petros Pharmaceuticals modifies terms with investors By Investing.com - Investing.com India

Harmony Biosciences chief commercial officer sells shares worth $1.15m - MSN

Microvast files for $250M mixed securities shelf offering - MSN

Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at over $38 Billion annually - ACCESS Newswire

Petros Pharmaceuticals Partners with Blockbuster Cholesterol Drug(1) Crestor’s (rosuvastatin) OTC Switch Technology Provider - ACCESS Newswire

Janbelco BV trims stake in Thalassa Holdings - MSN

Immedica to buy Marinus Pharmaceuticals for $151m - MSN

XORTX Therapeutics Announces Auditor Transition - MSN

Apellis Pharmaceuticals executive sells $36,998 in stock - MSN

Amneal gets FDA approval for generic Byetta, resubmits DHE NDA - MSN

Pharming Group appoints former Novartis USA President Fabrice Chouraqui as New CEO - MSN

Takeda-backed Ascentage Pharma targets $1.75 billion valuation in US IPO - MSN

Vincerx Pharma enters at-the-market equity offering deal - MSN

Mitsubishi Chemical picks Bain as preferred bidder for pharma unit, sources say - MSN

Sanofi receives GMP warning letter for Genzyme facility - MSN

Sinopharm Accord Projects Notable Profit Decline for 2024 - MSN

Comparing Petros Pharmaceuticals (NASDAQ:PTPI) & MoonLake Immunotherapeutics (NASDAQ:MLTX) - Defense World

AstraZeneca's Calquence gains FDA nod for 1L MCL treatment - MSN

FDA grants tentative approval for Amneal generic of Bausch Health's Xiafan - MSN

GoodRx Holdings announces CFO resignation; shares drop - MSN

Petronas may cut capex up to RM10b after Petro gas deal - The Malaysian Reserve

5 Best-performing Canadian Pharma Stocks (Updated January 2025) - MSN

Pre-market Movers: SANA, SLDB, JSPR, DRIO... - RTTNews

AMRN Stock Rises Over 5% Amidst Lack of Institutional Ratings - GuruFocus.com

GROUPIRA Co-Founder Petros Koumantaros Appointed to Washington Saves Governing Board - Yahoo Finance

Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews

Psychedelic Drug Therapy May Address Mental Health Concerns in People with Cancer & Addiction - NYU Langone Health

Petros Pharmaceuticals Inc (PTPI) 財務データ

収益

当期純利益

現金流量

EPS

PTPIに似た銘柄